Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility

Genes and Development

Volumn 21, Issue 14, 2007, Pages 1790-1802

  Montgomery, Rusty L ^a   Davis, Christopher A ^a   Potthoff, Matthew J ^a   Haberland, Michael ^a   Fielitz, Jens ^a   Qi, Xiaoxia ^a   Hill, Joseph A ^b   Richardson, James A ^a,b   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Heart development; Histone deacetylase; Transcription

Indexed keywords

CALCIUM CHANNEL; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRADYCARDIA; CARDIOMYOPATHY; CHROMATIN STRUCTURE; CONGESTIVE CARDIOMYOPATHY; DEATH; EMBRYO DEVELOPMENT; GENE DELETION; GENE EXPRESSION; GENETIC CODE; HEART ARRHYTHMIA; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HYPERPLASIA; IN VIVO STUDY; MORPHOGENESIS; MOUSE; NEWBORN PERIOD; NONHUMAN; NULL ALLELE; ORGANOGENESIS; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKELETAL MUSCLE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CALCIUM CHANNELS; CELL PROLIFERATION; FEMALE; FETAL HEART; GENE DELETION; GENE EXPRESSION; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HISTONE DEACETYLASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MORPHOGENESIS; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; PREGNANCY; REPRESSOR PROTEINS;

MUS;

EID: 34447511648     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1563807     Document Type: Article

References (41)

1. Agah, R., Frenkel, P.A., French, B.A., Michael, L.H., Overbeek, P.A., and Schneider, M.D. 1997. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100: 169-179.
2. Antos, C.L., McKinsey, T.A., Dreitz, M., Hollingsworth, L.M., Zhang, C.L., Schreiber, K., Rindt, H., Gorczynski, R.J., and Olson, E.N. 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278: 28930-28937.
3. Bodor, G.S., Oakeley, A.E., Allen, P.D., Crimmins, D.L., Ladenson, J.H., and Anderson, P.A. 1997. Troponin I phosphorylation in the normal and failing adult human heart. Circulation 96: 1495-1500.
4. Bolden, J.E., Peart, M.J., and Johnstone, R.W. 2006. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5: 769-784.
5. Davis, C.A., Haberland, M., Arnold, M.A., Sutherland, L.B., McDonald, O.G., Richardson, J.A., Childs, G., Harris, S., Owens, G.K., and Olson, E.N. 2006. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol. Cell. Biol. 26: 2626-2636.
6. Finnin, M.S., Donigian, J.R., Cohen, A., Richon, V.M., Rifkind, R.A., Marks, P.A., Breslow, R., and Pavletich, N.P. 1999. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
7. Gao, L., Cueto, M.A., Asselbergs, F., and Atadja, P. 2002. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277: 25748-25755.
8. Gregoretti, I.V., Lee, Y.M., and Goodson, H.V. 2004. Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J. Mol. Biol. 338: 17-31.
9. Grozinger, C.M. and Schreiber, S.L. 2002. Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors. Chem. Biol. 9: 3-16.
10. Grozinger, C.M., Hassig, C.A., and Schreiber, S.L. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. 96: 4868-4873.
11. Hassig, C.A., Tong, J.K., Fleischer, T.C., Owa, T., Grable, P.G., Ayer, D.E., and Schreiber, S.L. 1998. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. 95: 3519-3524.
12. Hill, J.A., Karimi, M., Kutschke, W., Davisson, R.L., Zimmerman, K., Wang, Z., Kerber, R.E., and Weiss, R.M. 2000. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101: 2863-2869.
13. Jenuwein, T. and Allis, C.D. 2001. Translating the histone code. Science 293: 1074-1080.
14. Kee, H.J., Sohn, I.S., Nam, K.I., Park, J.E., Qian, Y.R., Yin, Z., Ahn, Y., Jeong, M.H., Bang, Y.J., Kim, N., et al. 2006. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113: 51-59.
15. Khier, H., Bartl, S., Schuettengruber, B., and Seiser, C. 1999. Molecular cloning and characterization of the mouse histone deacetylase 1 gene: Integration of a retrovirus in 129SV mice. Biochim. Biophys. Acta 1489: 365-373.
16. Kobayashi, T. and Solaro, R.J. 2005. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu. Rev. Physiol. 67: 39-67.
17. Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B.A., Olson, E.N., and Hill, J.A. 2006. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113: 2579-2588.
18. Kuwahara, K., Saito, Y., Takano, M., Arai, Y., Yasuno, S., Nakagawa, Y., Takahashi, N., Adachi, Y., Takemura, G., Horie, M., et al. 2003. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22: 6310-6321.
19. Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21: 2672-2681.
20. Lin, H., Yutzey, K.E., and Konieczny, S.F. 1991. Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors. Mol. Cell. Biol. 11: 267-280.
21. Maglott, D., Ostell, J., Pruitt, K.D., and Tatusova, T. 2007. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res. 35 (Database issue): D26-D31. doi: 10.1093/nar/gkl993.
22. Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald III, E.R., Hurov, K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166.
23. McKinsey, T.A., Zhang, C.L., Lu, J., and Olson, E.N. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106-111.
24. Minucci, S. and Pelicci, P.G. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6: 38-51.
25. Nelson, J.D., Denisenko, O., Sova, P., and Bomsztyk, K. 2006. Fast chromatin immunoprecipitation assay. Nucleic Acids Res. 34: e2. doi: 10.1093/nar/gnj004.
26. Parmacek, M.S. and Solaro, R.J. 2004. Biology of the troponin complex in cardiac myocytes. Prog. Cardiovasc. Dis. 47: 159-176.
27. Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A.F., and Dymecki, S.M. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25: 139-140.
28. Roopra, A., Sharling, L., Wood, I.C., Briggs, T., Bachfischer, U., Paquette, A.J., and Buckley, N.J. 2000. Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol. Cell. Biol. 20: 2147-2157.
29. Roth, S.Y., Denu, J.M., and Allis, C.D. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70: 81-120.
30. Sakai, K. and Miyazaki, J. 1997. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun. 237: 318-324.
31. Sasse, S., Brand, N.J., Kyprianou, P., Dhoot, G.K., Wade, R., Arai, M., Periasamy, M., Yacoub, M.H., and Barton, P.J. 1993. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ. Res. 72: 932-938.
32. Shelton, J.M., Lee, M.H., Richardson, J.A., and Patel, S.B. 2000. Microsomal triglyceride transfer protein expression during mouse development. J. Lipid Res. 41: 532-537.
33. Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., and Narechania, A. 2003. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 13: 2129-2141.
34. Thomas, P.D., Kejariwal, A., Guo, N., Mi, H., Campbell, M.J., Muruganujan, A., and Lazareva-Ulitsky, B. 2006. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 34 (Web server issue): W645-W650. doi: 10.1093/nar/gkl229.
35. Thys, T.M., Blank, J.M., Coughlin, D.J., and Schachat, F. 2001. Longitudinal variation in muscle protein expression and contraction kinetics of largemouth bass axial muscle. J. Exp. Biol. 204: 4249-4257.
36. Trivedi, C.M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floss, T., Goettlicher, M., Noppinger, P.R., Wurst, W., et al. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat. Med. 13: 324-331.
37. Verdin, E., Dequiedt, F., and Kasler, H.G. 2003. Class II histone deacetylases: Versatile regulators. Trends Genet. 19: 286-293.
38. Voss, A.K., Thomas, T., and Gruss, P. 1998. Efficiency assessment of the gene trap approach. Dev. Dyn. 212: 171-180.
39. Xin, M., Davis, C.A., Molkentin, J.D., Lien, C.L., Duncan, S.A., Richardson, J.A., and Olson, E.N. 2006. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. 103: 11189-11194.
40. Yang, W.M., Yao, Y.L., Sun, J.M., Davie, J.R., and Seto, E. 1997. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272: 28001-28007.
41. 2+ channels in fetal and diseased heart. J. Pharmacol. Sci. 99: 205-210.